Jul 16, 2024
Comments to FDA: First Amendment Issues
Docket Number:
02N-0209
CHPA endorses PhRMA’s analysis and conclusions concerning the First Amendment protections for trade names. These legal principles apply equally to the selection and use of trade names for OTC medicine and dietary supplement products.
Issues: